{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:26:15Z","timestamp":1788175575768,"version":"build-2803163510"},"reference-count":33,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2017,2,18]],"date-time":"2017-02-18T00:00:00Z","timestamp":1487376000000},"content-version":"vor","delay-in-days":323,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility and may be associated with adverse pregnancy and neonatal outcomes. However, it is difficult to establish how much of this risk is due to PCOS and how much to obesity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>This study aimed to determine the effect of PCOS upon fertility, pregnancy, and neonatal outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design and Setting:<\/jats:title>\n                  <jats:p>Data were extracted from the Clinical Practice Research Datalink (CPRD), a longitudinal anonymized primary care research database in the United Kingdom. Patients with a diagnosis of PCOS were matched to controls (1:2) by age (\u00b11 y), body mass index (\u00b1 3 U), and CPRD practice. Standardized fertility ratios before and after diagnosis (index date) were calculated. Rates of miscarriage, pre-eclampsia, gestational diabetes, premature delivery, delivery method, and neonatal outcomes were compared.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Nine thousand sixty-eight women with PCOS matched study criteria. Prior to index date the standardized fertility ratio for patients with PCOS was 0.80 (95% confidence interval, 0.77\u20130.83); following index date it was 1.16 (1.12\u20131.20). The adjusted odds ratios (95% CI) for miscarriage (1.70; 1.56\u20131.84), pre-eclampsia (1.32; 1.16\u20131.49), gestational diabetes (1.41; 1.2\u20131.66), and premature delivery (1.25; 1.1\u20131.43) were all increased compared with controls. Of PCOS births, 27.7% were by Caesarean section compared with 23.7% of controls (1.13; 1.05\u20131.21). Infants born to mothers with PCOS had an increased risk of neonatal jaundice (1.20; 1.03\u20131.39) and respiratory complications (1.20; 1.06\u20131.37).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>PCOS is associated with subfertility but fertility rates are restored to those of the background population following diagnosis. Pregnancy complications and adverse neonatal outcomes are more prevalent for women with PCOS independently of obesity.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2015-2682","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T18:03:53Z","timestamp":1455041033000},"page":"1664-1672","source":"Crossref","is-referenced-by-count":64,"title":["Contemporary Reproductive Outcomes for Patients With Polycystic Ovary Syndrome: A Retrospective Observational Study"],"prefix":"10.1210","volume":"101","author":[{"given":"D. Aled","family":"Rees","sequence":"first","affiliation":[{"name":"Neurosciences and Mental Health Research Institute (D.A.R.), School of Medicine, Cardiff University, Cardiff CF24 4HQ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Jenkins-Jones","sequence":"additional","affiliation":[{"name":"Pharmatelligence (S.J.-J.), Cardiff Medicentre, Heath Park, Cardiff CF14 4UJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Institute of Primary Care and Public Health (C.L.M.) Cardiff CF24 4HQ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071614480610300_B1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614480610300_B2","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asunci\u00f3n","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614480610300_B3","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.2012-1690","article-title":"Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: A retrospective, observational study","volume":"97","author":"Morgan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614480610300_B4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"2020071614480610300_B5","doi-asserted-by":"crossref","first-page":"L1805","DOI":"10.1016\/j.fertnstert.2009.10.043","article-title":"Pregnancy in women with polycystic ovary syndrome: The effect of different phenotypes and features on obstetric and neonatal outcomes","volume":"94","author":"Palomba","year":"2010","journal-title":"Fertil Steril"},{"key":"2020071614480610300_B6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0015-0282(01)02941-7","article-title":"Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome","volume":"77","author":"Kocak","year":"2002","journal-title":"Fertil Steril"},{"key":"2020071614480610300_B7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0015-0282(00)01675-7","article-title":"Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone","volume":"75","author":"Vandermolen","year":"2001","journal-title":"Fertil Steril"},{"key":"2020071614480610300_B8","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1600-0412.2012.01385.x","article-title":"Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: An overview","volume":"91","author":"Ghazeeri","year":"2012","journal-title":"Acta Obstet Gynecol"},{"key":"2020071614480610300_B9","doi-asserted-by":"crossref","first-page":"d6309","DOI":"10.1136\/bmj.d6309","article-title":"Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: Population based cohort study","volume":"343","author":"Roos","year":"2011","journal-title":"BMJ"},{"key":"2020071614480610300_B10","unstructured":"MHRA. The Clinical Practice Research Datalink. Available from: http:\/\/www.cprd.com. Last accessed April 8, 2015"},{"key":"2020071614480610300_B11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0031-3955(16)31874-0","article-title":"The newborn (Apgar) scoring system. Reflections and advic","volume":"13","author":"Apgar","year":"1966","journal-title":"Pediatr Clin North Am"},{"key":"2020071614480610300_B12","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/humrep\/den482","article-title":"Long-term follow-up of patients with polycystic ovary syndrome: Reproductive outcome and ovarian reserve","volume":"24","author":"Hudecova","year":"2009","journal-title":"Hum Reprod"},{"key":"2020071614480610300_B13","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0026-0495(99)90250-0","article-title":"Plasminogen activator inhibitor activity: An independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome","volume":"48","author":"Glueck","year":"1999","journal-title":"Metabolism"},{"key":"2020071614480610300_B14","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1093\/humrep\/16.12.2606","article-title":"Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment","volume":"16","author":"Wang","year":"2001","journal-title":"Hum Reprod"},{"key":"2020071614480610300_B15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0015-0282(00)01666-6","article-title":"Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: A pilot study","volume":"75","author":"Glueck","year":"2001","journal-title":"Fertil Steril"},{"key":"2020071614480610300_B16","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/humrep\/17.11.2858","article-title":"Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin","volume":"17","author":"Glueck","year":"2002","journal-title":"Hum Reprod"},{"key":"2020071614480610300_B17","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jcem.87.2.8207","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome","volume":"87","author":"Jakubowicz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614480610300_B18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.beem.2006.03.009","article-title":"Pregnancy complications in PCOS","volume":"20","author":"Homburg","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"2020071614480610300_B19","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2337\/dc06-0877","article-title":"Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: A population-based study","volume":"29","author":"Lo","year":"2006","journal-title":"Diabetes Care"},{"key":"2020071614480610300_B20","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/humrep\/deg289","article-title":"Pregnancy outcome in women with PCOS and in controls matched by age and weight","volume":"18","author":"Haakova","year":"2003","journal-title":"Hum Reprod"},{"key":"2020071614480610300_B21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/10641959909009612","article-title":"Are women with polycystic ovary syndrome at an increased risk of pregnancy-induced hypertension and\/or preeclampsia?","volume":"18","author":"Fridstr\u00f6m","year":"1999","journal-title":"Hypertens Pregnancy"},{"key":"2020071614480610300_B22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/humrep\/16.2.226","article-title":"Obstetric outcome in women with polycystic ovarian syndrome","volume":"16","author":"Mikola","year":"2001","journal-title":"Hum Reprod"},{"key":"2020071614480610300_B23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0301-2115(97)00164-4","article-title":"Higher risk of preeclampsia in the polycystic ovary syndrome: A case control study","volume":"1","author":"de Vries","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2020071614480610300_B24","doi-asserted-by":"crossref","first-page":"558.e1","DOI":"10.1016\/j.ajog.2011.03.021","article-title":"Pregnancy outcomes in women with polycystic ovary syndrome: A meta-analysis","volume":"204","author":"Kjerulff","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"2020071614480610300_B25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejogrb.2009.11.010","article-title":"Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes","volume":"149","author":"Altieri","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2020071614480610300_B26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/09513590400007242","article-title":"Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome","volume":"19","author":"Weerakiet","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"2020071614480610300_B27","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/humrep\/deu154","article-title":"A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome","volume":"29","author":"De Fr\u00e8ne","year":"2014","journal-title":"Hum Reprod"},{"key":"2020071614480610300_B28","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1210\/jc.2010-0853","article-title":"Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study","volume":"95","author":"Vanky","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614480610300_B29","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.fertnstert.2008.08.087","article-title":"Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials","volume":"92","author":"Palomba","year":"2009","journal-title":"Fertil Steril"},{"key":"2020071614480610300_B30","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1210\/jc.2011-3061","article-title":"Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): A multicenter, double-blind, placebo-controlled randomized trial","volume":"97","author":"Morin-Papunen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614480610300_B31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/1471-0528.12443","article-title":"Association between maternal body mass index during pregnancy, short-term morbidity, and increased health service costs: A population-based study","volume":"121","author":"Denison","year":"2014","journal-title":"BJOG"},{"key":"2020071614480610300_B32","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/humrep\/dei009","article-title":"Birth weight in offspring of mothers with polycystic ovarian syndrome","volume":"20","author":"Sir-Petermann","year":"2005","journal-title":"Hum Reprod"},{"key":"2020071614480610300_B33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1479-828X.2000.tb03167.x","article-title":"Prevalence of gestational diabetes mellitus in polycystic ovarian syndrome (PCOS) patients pregnant after ovulation induction with gonadotrophins","volume":"40","author":"Vollenhoven","year":"2000","journal-title":"Aust NZ J Obstet Gynaecol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/4\/1664\/20287824\/jcem1664.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/4\/1664\/20287824\/jcem1664.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T02:23:57Z","timestamp":1594952637000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/101\/4\/1664\/2804548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2015-2682","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,1]]}}}